A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multi-center Study to Evaluate the Efficacy, Safety and Tolerability of Combinations of Solifenacin Succinate and Mirabegron Compared to Solifenacin Succinate and Mirabegron Monotherapy in the Treatment of Overactive Bladder
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multi-center Study to Evaluate the Efficacy, Safety and Tolerability of Combinations of Solifenacin Succinate and Mirabegron Compared to Solifenacin Succinate and Mirabegron Monotherapy in the Treatment of Overactive Bladder
The purpose of this study was to examine how well two medicines (solifenacin succinate and mirabegron) combined work compared to each medicine alone in the treatment of bladder problems.
Inclusion Criteria:
Exclusion Criteria:
Grand Rapids, Michigan 49503, United States
Bala-Cynwyd, Pennsylvania 19004, United States
Austin, Texas 78745, United States
Sandy City, Utah 84070, United States
Ciudad Autónoma Buenos Aires, C1120AAT, Argentina
Rosario Provincia de Santa Fe, 2000, Argentina
North York, Ontario M2J 1V1, Canada
Point-Claire, Quebec H9R 4S3, Canada
Milan, 20132, Italy
Iksan -Si, 570-711, South Korea
Esplugues de Llobregat-Barcelo, 08950, Spain
Dnipropetrovsk, 49005, Ukraine